ALKAL2 and neuroblastoma: Given the observation that “2p‐gain” patients exhibit a poor prognosis within the NB patient population, our hypothesis was that ALKAL2 dysregulation may be able to promote initiation and progression of NB (Jeison et al, 2010; Javanmardi et al, 2019).